A system for treating a patient, including a computerized device with a display and a communication interface for communicating with remote mobile devices, one or more sensors for measuring medical parameters of a user, wherein the sensors are controlled by the computerized device and transfer recorded measurements to the computerized device, an application executed on the computerized device; wherein the application allows, a remote practitioner with a remote mobile device to communicate with the computerized device to control the sensors.

Described here are meters and methods for sampling, transporting, and/or analyzing a fluid sample. The meters may include a meter housing and a cartridge. In some instances, the meter may include a tower which may engage one or more portions of a cartridge. The meter housing may include an imaging system, which may or may not be included in the tower. The cartridge may include one or more sampling arrangements, which may be configured to collect a fluid sample from a sampling site. A sampling arrangement may include a skin-penetration member, a hub, and a quantification member.

A detection device for cannabinoid use including a base unit and a display screen disposed on the base unit. A central processing unit and a tetrahydrocannabinol testing device are disposed within the base unit. A testing slot is disposed on a bottom portion of the base unit, with a back end of the testing slot disposed within the tetrahydrocannabinol testing device. Each of a plurality of testing strips is slidably and removably disposed within the testing slot. A printer has a pair of T-shaped attachment extensions. Each of the pair of attachment extensions and a universal serial bus plug disposed on the printer simultaneously removably and slidably engages each of a pair of attachment slots and a universal serial bus port disposed on the base unit, respectively. The tetrahydrocannabinol testing device is configured to analyze and calculate the presence and amount of tetrahydrocannabinol in a person's bloodstream.

Systems for the delivery of insulin to a patient, the system comprising: a continuous glucose sensor configured to provide a glucose level signal representative of sensed glucose; an insulin delivery device configured to deliver insulin in response to delivery control signals at a basal rate and as a bolus; and a controller programmed to receive the sensor glucose level signal and to provide a delivery control signal to an insulin delivery device to suspend a basal delivery rate during the provision of a bolus delivery and to automatically resume a preprogrammed basal delivery rate after a selected event.

Embodiments of the present disclosure provide code readers for reading codes provided as patterns imprinted on objects. Light interacts with a pattern by e.g. being reflected from or transmitted through the pattern, and at least some of the light that has interacted with the pattern is incident on photosensitive element(s) of one or more photodetectors of a code reader. The code reader employs centroid-measuring photodetector(s), i.e. photodetectors that detect light in such a manner that centroid of a pattern can be obtained directly from the photocurrents generated as a result of the photosensitive elements detecting light incident thereon. The code reader is then configured to process the detected light to determine a centroid of the pattern from the detected light and to decode data encoded in the pattern based on a position of the centroid. Such code readers are substantially less complex than camera-based devices and avoid mechanical scanning.

Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.

Disclosed herein are embodiments of a continuous analyte sensor that can be used to measure glucose or lactate levels in a patient, along with other analytes. In some embodiments, the sensor can be located in the tissue or a blood vessel of a patient, and a probe can be located on the skin of the patient generally adjacent to the sensor. The probe can detect luminescent signals that originate from the sensor and that are dependent on analyte levels.

An electrochemically active device is provided for collecting and retaining a blood sample with at least a two-electrode member connected to conductive tracks. A receptor with an integral receptor-membrane arranged on the two-electrode member, to receive non-electrochemically active heamoglobin bioanalyte and its complexes from red blood cells (RBC) of said blood sample, through a lysing agent and convert the non-electrochemically active heamoglobin bioanalyte and its complexes, into an electrochemically active bioanalyte and its electrochemically active complexes. The present invention also provides a point-of-care biosensor incorporated with the device of the present invention and method of measuring for the detection and quantitative measurement of concentrations of haemoglobin (Hb), glycated haemoglobin (GHb), methaemoglobin (MetHb) and myoglobin, in reduced volumes of blood samples, by determining redox current values in the reduced volumes of blood samples.

Bodily fluid indicator devices and methods are provided. Such devices and methods can effectively indicate whether the amount of bodily fluid being produced is within a measurable range. In an exemplary embodiment, a bodily fluid indicator device includes a substrate having a surface. Some portions of the surface are covered with a region of absorbent material and other portions of the surface are devoid of the absorbent material. A graduated scale or a reactive feature is printed on the absorbent material. The device is configured to indicate an amount and/or a composition a bodily fluid present on an area of a patient or subject.

A portable medical apparatus including at least a sampling assembly for providing at least one sample of a fluid in an object, a detector for determining at least one parameter of the fluid, an injector for performing at least one injection of an injection medium, and which are operable independent of each other for improved self-treatment of diseases such as diabetes. The portable medical apparatus has a single common housing for these components and a switch for changing between the sampling mode, the determining mode, and the injection mode. The apparatus also includes an actuator means for individually actuating the other components. The apparatus is an all-in-one device that facilitates the medical treatment process for patients, medical professionals or others.